krp-203

Small moleculeexperimental

Clinical trial activity

3 trials · 1 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Dec 1, 2010 (NCT01375179)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2013

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • krp203
  • krp203
  • krp-203
  • krp-203

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT01830010Phase 1Jun 28, 2013Novartis
NCT01294774Phase 2Feb 1, 2011Novartis
NCT01375179Phase 2Dec 1, 2010Novartis
Showing 3 of 3 trials
Page 1 / 1

Organizations

Research & Development (1)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
NovartisFor profit3322010
1 organizations
Page 1 / 1